Therapeutic Enzymes Market

Therapeutic enzymes have a broad variety of specific uses, Oncolytics, Anticoagulants, Thrombolytics, Replacements for metabolic deficiencies, Digestive aids, Metabolic storage disorders, etc. Miscellaneous enzymes of diverse function.

Therapeutic Enzymes Market contains market size and forecasts of Therapeutic Enzymes in global, including the following market information:

Global Therapeutic Enzymes Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Therapeutic Enzymes Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Therapeutic Enzymes companies in 2021 (%)

The global Therapeutic Enzymes market was valued at 7701.9 million in 2021 and is projected to reach US$ 16580 million by 2028, at a CAGR of 11.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injectable Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Therapeutic Enzymes include Sanofi, BioMarin, AbbVie, Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson and Recordati Rare Diseases, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Therapeutic Enzymes manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Therapeutic Enzymes Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Therapeutic Enzymes Market Segment Percentages, by Type, 2021 (%)

• Injectable
• Oral
• Topical

Global Therapeutic Enzymes Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Therapeutic Enzymes Market Segment Percentages, by Application, 2021 (%)

• Gaucher Disease
• MPS Disease
• Gastrointestinal Diseases
• Others

Global Therapeutic Enzymes Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Therapeutic Enzymes Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Therapeutic Enzymes revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Therapeutic Enzymes revenues share in global market, 2021 (%)
• Key companies Therapeutic Enzymes sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Therapeutic Enzymes sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• BioMarin
• AbbVie
• Shire
• Alexion
• Horizon Pharma
• Allergan
• Johnson & Johnson
• Recordati Rare Diseases
• Pfizer
• Vivus
• Digestive Care
• Leadiant Biosciences